Regarding acute leukemias, the BCR::ABL1 rearrangement can, therefore, be detected in AML arising from BC-CML, in de novo AML, and throughout the course of AML, as a secondary event. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.